General Information

Serenity Bioworks Inc.

	Address	1406 Laburnum St Vancouver, V6J 3W3 Canada
	Address type	Registered Office Address
	Address province	British Columbia

	Corporation ID	10198579
	Business number	718540891
	Status	Dissolved
	ACT	Canada Business Corporations Act
	Status details	Dissolved by the corporation
	Anniversary date	04/19/2017
	Last annual filing	2026
	Data verified	10/31/2026

Description

Serenity Bioworks Inc. is a dissolved establishment registered under Canada Business Corporations Act with a corporation number 10198579 (business no 718540891). The incorporation was completed on 2017-04-19. The company is headquartered in Vancouver at 1406 Laburnum St, V6J 3W3 in British Columbia administrative division.
Additional enterprises nearby include: Mind Flow Productions Inc., Ctrl-Freq Corp., Ben Clarke Holdings Inc., Citizen Model, Collings Johnston Inc..

Location: Statistics Canada, Open Database of Addresses (Open Government Licence – Canada).

Company names

Name	Effective date	Type	Current
SERENITY BIOWORKS INC.	04/19/2017	Corporate Name	true

Directors

Cody Shirriff
,

last updated: 2026-10-30

Government Grants and Contributions

5 federal grants and contributions between 2020 and 2021 with a total value of $251,037.

Start date	Department and program	Value
05/02/2021	National Research Council Canada Industrial Research Assistance Program – Contributions to Firms (contribution) Development of immunomodulatory biotherapeutics for the treatment of lupus nephritis Serenity Bioworks is conducting drug-development studies to gain a better understanding of the interaction and effectiveness of its lead biotherapeutic in combination with the standard of care drugs in an autoimmune disease, lupus nephritis.	$90,000
12/20/2020	National Research Council Canada Industrial Research Assistance Program – Innovation Assistance Program (contribution) Innovation Assistance Program – Round 2.5 The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.	$21,676
06/25/2020	National Research Council Canada Industrial Research Assistance Program – Innovation Assistance Program (contribution) Innovation Assistance Program – Round 2 The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support	$48,705
04/06/2020	National Research Council Canada Industrial Research Assistance Program – Contributions to Firms (contribution) Feasibility study: Production of a nanoparticle-encapsulated biotherapeutic for the treatment of autoimmune diseases Serenity Bioworks is conducting a feasibility study to produce the second-generation biotherapeutics for the treatment of autoimmune diseases with unmet medical needs.	$50,000
04/01/2020	National Research Council Canada Innovation Assistance Program (contribution) The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.	$40,656

Source: Government of Canada, proactive disclosure of grants and contributions. Contains information licensed under the Open Government Licence – Canada.

Company activities

Date	Type	Section
05/24/2019	Amendment	6
04/19/2017	Incorporation